Mark P Labrecque

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Holly M Nguyen, Susan Dalrymple, W Nathaniel Brennen, John T Isaacs, Dapei Li, Bryce Lakely, Diana C DeLucia, John K Lee, Michael T Schweizer, Daniel W Lin, Eva Corey, Peter S Nelson, Colm Morrissey
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer. The Prostate (2023)
Ailin Zhang, Nathan A Lau, Alicia Wong, Lisha G Brown, Ilsa M Coleman, Navonil DeSarkar, Dapei Li, Diana C DeLucia, Mark P Labrecque, Holly M Nguyen, Jennifer L Conner, Ruth F Dumpit, Lawrence D True, Daniel W Lin, Eva Corey, Joshi J Alumkal, Peter S Nelson, Colm Morrissey, John K Lee
Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers. Cancer research communications (2023)
Dae-Hwan Kim, Duanchen Sun, William K Storck, Katherine Welker Leng, Chelsea Jenkins, Daniel J Coleman, David Sampson, Xiangnan Guan, Anbarasu Kumaraswamy, Eva S Rodansky, Joshua A Urrutia, Jacob A Schwartzman, Chao Zhang, Himisha Beltran, Mark P Labrecque, Colm Morrissey, Jared M Lucas, Ilsa M Coleman, Peter S Nelson, Eva Corey, Samuel K Handelman, Jonathan Z Sexton, Rahul Aggarwal, Wassim Abida, Felix Y Feng, Eric J Small, Daniel E Spratt, Armand Bankhead, Arvind Rao, Emily M Gesner, Sarah Attwell, Sanjay Lakhotia, Eric Campeau, Joel A Yates, Zheng Xia, Joshi J Alumkal
BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Holly M Nguyen, Daniel W Lin, Eva Corey, Peter S Nelson, Colm Morrissey
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature. PloS one 16 (1) (2021)
Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Bryce Lakely, Nicholas J Brady, John K Lee, Holly M Nguyen, Dapei Li, Brian Hanratty, Michael C Haffner, David S Rickman, Lawrence D True, Daniel W Lin, Hung-Ming Lam, Joshi J Alumkal, Eva Corey, Peter S Nelson, Colm Morrissey
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer. Cancer research 81 (18) (2021)
Diana C DeLucia, Thomas M Cardillo, Lisa Ang, Mark P Labrecque, Ailin Zhang, James E Hopkins, Navonil DeSarkar, Ilsa Coleman, Rui Miguel Gil da Costa, Eva Corey, Lawrence D True, Michael C Haffner, Michael T Schweizer, Colm Morrissey, Peter S Nelson, John K Lee
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (3) (2020)